Russian Brief Pain Inventory: Validation and Application in Cancer Pain

Journal of Pain and Symptom Management

Volumn 35, Issue 1, 2008, Pages 95-102

  Kalyadina, Svetlana A ^a   Ionova, Tatyana I ^a   Ivanova, Maria O ^a   Uspenskaya, Olga S ^a   Kishtovich, Anton V ^a   Mendoza, Tito R ^b   Guo, Hong ^b   Novik, Andrei ^c   Cleeland, Charles S ^b   Wang, Xin S ^b  

^a National Cancer Research and Treatment Center   (Russian Federation)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Pirogov National Medical Surgical Center   (Russian Federation)

Author keywords

BPI; Pain Management Index; Russia; validation

Indexed keywords

ANALGESIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BRIEF PAIN INVENTORY; CANCER PAIN; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; RATING SCALE; SOLID TUMOR; VALIDATION STUDY; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; DATA COLLECTION; FEMALE; HUMANS; LANGUAGE; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; REPRODUCIBILITY OF RESULTS; RUSSIA;

EID: 37349068858     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2007.02.042     Document Type: Article

References (28)

1. Osipova N.A., Novikov G.A., and Prokhorov B.M. Chronic cancer pain (1998), Medicine, Moscow
2. Serlin R.C., Mendoza T.R., Nakamura Y., Edwards K.R., and Cleeland C.S. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain 61 2 (1995) 277-284
3. Teoh N., and Stjernsward J. WHO cancer pain relief program-ten years on. IASP Newsletter (1992) July/August 5-6
4. Ventafridda V., Caraceni A., and Gamba A. Field-testing of the WHO Guidelines for Cancer Pain Relief: summary report of demonstration projects. In: Foley K.M., Bonica J.J., and Ventafridda V. (Eds). Advances in Pain Research and Therapy, Proceedings of the Second International Congress on Cancer Pain Vol. 16 (1990), Raven Press, New York 451-464
5. World Health Organization. Cancer pain relief (1986), World Health Organization, Geneva
6. Cleeland C.S., Gonin R., Hatfield A.K., et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330 9 (1994) 592-596
7. The International Observatory on End-of-Life Care. Opioid availability and consumption in Russia. Available from. http://www.eolc-observatory.net/global_analysis/russia_opioid.htm Accessed October 6, 2006
8. Cleeland C.S. Measurement of pain by subjective report. In: Chapman C.R., and Loeser J.D. (Eds). Advances in Pain Research and Therapy. Issues in Pain Measurement Vol. 12 (1989), Raven Press, New York 391-403
9. Cleeland C.S., and Ryan K.M. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singap 23 2 (1994) 129-138
10. Badia X., Muriel C., Gracia A., et al. Validation of the Spanish version of the Brief Pain Inventory in patients with oncological pain. [in Spanish]. Med Clin (Barc) 120 2 (2003) 52-59
11. Caraceni A., Mendoza T.R., Mencaglia E., et al. A validation study of an Italian version of the Brief Pain Inventory [Breve Questionario per la Valutazione del Dolore]. Pain 65 1 (1996) 87-92
12. Cleeland C.S., Nakamura Y., Mendoza T.R., et al. Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. Pain 67 2-3 (1996) 267-273
13. Ger L.P., Ho S.T., Sun W.Z., Wang M.S., and Cleeland C.S. Validation of the Brief Pain Inventory in a Taiwanese population. J Pain Symptom Manage 18 5 (1999) 316-322
14. Klepstad P., Loge J.H., Borchgrevink P.C., et al. The Norwegian Brief Pain Inventory questionnaire: translation and validation in cancer pain patients. J Pain Symptom Manage 24 5 (2002) 517-525
15. Laudico A.V., Mendoza T.R., Siguan S.S., and Cleeland C.S. Measuring cancer pain intensity and its effect on daily functioning: validation of the Cebuano version of the Brief Pain Inventory (BPI-Ce). Philipp J Surg Spec 57 3 (2002) 94-99
16. Mystakidou K., Mendoza T., Tsilika E., et al. Greek Brief Pain Inventory: validation and utility in cancer pain. Oncology 60 1 (2001) 35-42
17. Radbruch L., Loick G., Kiencke P., et al. Validation of the German version of the Brief Pain Inventory. J Pain Symptom Manage 18 3 (1999) 180-187
18. Saxena A., Mendoza T., and Cleeland C.S. The assessment of cancer pain in north India: the validation of the Hindi Brief Pain Inventory-BPI-H. J Pain Symptom Manage 17 1 (1999) 27-41
19. Uki J., Mendoza T., Cleeland C.S., Nakamura Y., and Takeda F. A brief cancer pain assessment tool in Japanese: the utility of the Japanese Brief Pain Inventory-BPI-J. J Pain Symptom Manage 16 6 (1998) 364-373
20. Wang X.S., Mendoza T.R., Gao S.Z., and Cleeland C.S. The Chinese version of the Brief Pain Inventory (BPI-C): its development and use in a study of cancer pain. Pain 67 2-3 (1996) 407-416
21. Yun Y.H., Mendoza T.R., Heo D.S., et al. Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the Brief Pain Inventory. Oncology 66 6 (2004) 439-444
22. Ware J.E., and Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30 6 (1992) 473-483
23. Harman H.H. Modern factor analysis. 2nd revised ed. (1967), University of Chicago Press, Chicago, IL
24. Hosmer Jr. D.W., and Lemenshow S. Applied logistic regression (1989), John Wiley & Sons, Incorporated, New York
25. Gorsuch R.L. Factor analysis (1974), Saunders, Philadelphia, PA
26. Larue F., Colleau S.M., Brasseur L., and Cleeland C.S. Multicentre study of cancer pain and its treatment in France. BMJ 310 6986 (1995) 1034-1037
27. Cleeland C.S., Gonin R., Baez L., Loehrer P., and Pandya K.J. Pain and treatment of pain in minority patients with cancer. The Eastern Cooperative Oncology Group Minority Outpatient Pain Study. Ann Intern Med 127 9 (1997) 813-816
28. von Roenn J.H., Cleeland C.S., Gonin R., Hatfield A.K., and Pandya K.J. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med 119 2 (1993) 121-126